Planar and tomographic imaging dosimetry comparing to develop a new radiopharmaceutical for melanoma therapy
DOI:
https://doi.org/10.15392/bjrs.v8i2.1191Keywords:
preclinical dosimetry, 99mTc- Ixolaris, SPECT, imaging dosimetry method.Abstract
This work aims to compare SPECT (Single Photon Emission Tomography Computed) and planar modalities as the most efficient methodology to perform dosimetry by molecular imaging. Twenty-one male C57BL6 mice induced with murine melanoma cell line B16-F10, administered 131I-Ixolaris were used for melanoma therapy. The procedures applied to them followed the standards described for the use of experimental animals, duly approved by the National Council for Animal Experimentation Control (CONCEA from Federal University of Rio de Janeiro. The accumulated activities were obtained in order to estimate the absorbed doses in each organ. Mass and metabolic differences between mice and humans were considered and used to extrapolate data acquired at different scales. From the dose factors provided by the MIRDOSE software, the absorbed doses in the target organs irradiated by the source organs were calculated and, finally, the effective dose was estimated. From the Student's t-hypothesis test performed in the accumulated activity, absorbed dose and S-factor quantities, there is no statistically significant difference between performing the image dosimetry from SPECT and planar acquired images.
Downloads
References
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Resolução – RDC n° 64 – Dispõe sobre o Registro de Radiofármacos, Brasil, 2009.
GERDEKOOHI1, S., VOSOUGHI1, N., TANHA, K. Implementation of absolute quantifi-cation in small-animal SPECT imaging: Phantom and animal studies. Medical Imaging, 2016.
ZAIDI, H. Quantitative Analysis in Nuclear Medicine, Switzerland, Springer, 2006.
MATHER, S. Molecular Imaging with Bioconjugates in Mouse Models of Cancer. Ameri-can Chemical Society, v.20(4), 2009.
FRAKER P.J., SPECK J.C. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun, v.80(4), p.849–57, 1978.
KAMESWARAN M., SARMA HD., DASH A. Preclinical evaluation of131I-Bevacizumab
– A prospective agent for radioimmunotherapy in VEGF expressing cancers. Appl
Radiat Isot. Elsevier Ltd. v.123, p.109–13, 2017.
ÜNAK T., AKGÜN Z., YILDIRIM Y., DUMAN Y., ERENEL G. Self-radioiodination of iodogen. Appl Radiat Isot, v.54(5), p.749–52, 2001.
SORIANO, S.C.S., SOUZA, S.A.L., BARBOZA, T. e DE SÁ, L.V. The image reconstruc-tion influence in relative measurement in SPECT / CT animal”. Brazilian Journal of Radi-ation Sciences, 2018.
MCPARLAND, B.J. Nuclear Medicine Radiation Dosimetry - Advanced Theoretical Principles. 1st ed. Springer; 2010.
STABIN, M.G. Fundamentals of Nuclear Medicine Dosimetry, USA, Springer; 2008.
ELVAS, VANGESTEL, C., RAPIC, S. Characterization of 99mTc- Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis. Mol Imaging Biol, 2015.
International Comission on Radiological Protection – ICRP. Recommendations of the International Commission on Radiological Protection. ICRP Publication 103, 2007.
BARBOZA, T.; GOMES, T.; MIZURINI, D. 99mTc-ixolaris targets glioblastoma- associated tissue factor: In vitro and pre-clinical applications. Thrombosis Research, v. 15, p. S0049, 2015.
Published
Issue
Section
License
Copyright (c) 2020 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
How to Cite
